Cross-sectional survey on patients experience with suvorexant and other hypnotics in insomnia patients with nocturia

Cross-sectional survey on patients experience with suvorexant and other hypnotics in insomnia patients with nocturia - Cross-sectional survey on patients experience with suvorexant and other hypnotics in insomnia patients with nocturia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030826

Enrollment

240

Registered

2018-01-15

Start date

2018-01-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia with nocturia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age 40 years or older Nocturia outpatients with experience of using suvorexant monotherapy or other sleep medication monotherapy during the most recent 30 day period prior to survey fielding Stable treatment for nocturia (no change in medical treatment for nocturia, no history of invasive treatment for nocturia, within 3 months prior to survey fielding)

Exclusion criteria

Exclusion criteria: The following disease or symptom: cognitive impairment chronic pain restless leg syndrome sleep related breathing disorder acute urinary tract infection prostate cancer urinary tract cancer

Design outcomes

Primary

Measure	Time frame
Patient experiences with suvorexant including: dosing, frequency of use, symptom relief and satisfaction in insomnia patients with nocturia	—

Secondary

Measure	Time frame
Patient experiences with other sleep medications including: dosing, frequency of use, symptom relief and satisfaction in insomnia patients with nocturia	—

Countries

Japan

Contacts

Public ContactShoki Okuda

MSD K.K. Medical Affairs

ldgproject@merck.com03-6272-1067

Outcome results